Lycopene attenuated hepatic tumorigenesis via differential mechanisms depending on carotenoid cleavage enzyme in mice

Chest

Volumn 146, Issue 6, 2014, Pages 1219-1227

  Ip, Blanche C ^a,b   Liu, Chun ^a   Ausman, Lynne M ^a,b   Von Lintig, Johannes ^c   Wang, Xiang Dong ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE 9',10' OXYGENASE; BETA CATENIN; INITIATION FACTOR 2ALPHA; INTERLEUKIN 6; LYCOPENE; MESSENGER RNA; MICRORNA; MICRORNA 199A; MICRORNA 199B; MICRORNA 214; OXYGENASE; SCATTER FACTOR RECEPTOR; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; ANTINEOPLASTIC AGENT; BCO2 PROTEIN, MOUSE; CAROTENOID; DIOXYGENASE; CARCINOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PROTEIN KINASE; SYNAPTOTAGMIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CANCER GROWTH; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM STRESS; ENZYME MODIFICATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MET GENE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THERAPY EFFECT; TUMOR GENE; UNFOLDED PROTEIN RESPONSE; ANIMAL; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION; DRUG EFFECTS; ENZYME IMMUNOASSAY; GENETICS; HUMAN; KNOCKOUT MOUSE; LIPID DIET; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING; CANCER INCIDENCE; ENDOPLASMIC RETICULUM; HEPATITIS; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; ANTICARCINOGENIC AGENTS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CAROTENOIDS; CELL TRANSFORMATION, NEOPLASTIC; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; DIOXYGENASES; ENDOPLASMIC RETICULUM STRESS; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84919360294     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-14-0154     Document Type: Article

References (60)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012;379:1245-55.
3. Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in nonalcoholic fatty liver disease: an emerging menace. J Hepatol 2012; 56:1384-91.
4. Sporn MB, Liby KT. Is lycopene an effective agent for preventing prostate cancer? Cancer Prev Res 2013;6:384-6.
5. Singh S, Singh PP, Roberts LR, Sanchez W. Chemopreventive strategies in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2014;11:45-54.
6. Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010;140:197-208.
7. Wang Y, Ausman LM, Greenberg AS, Russell RM, Wang XD. Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats. Int J Cancer 2009;124:540-6.
8. He G, Yu GY, Temkin V, Ogata H, Kuntzen C, Sakurai T, et al. Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell 2010;17:286-97.
9. Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 2012;13:89-102.
10. Fu S, Watkins SM, Hotamisligil GS. The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab 2012;15:623-34.
11. Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol 2011;54:795-809.
12. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 1999;91:317-31.
13. Wang XD. Lycopene metabolism and its biological significance. Am J Clin Nutr 2012;96:1214S-22S.
14. Story EN, Kopec RE, Schwartz SJ, Harris GK. An update on the health effects of tomato lycopene. Annu Rev Food Sci Technol 2010;1: 189-210.
15. Erhardt A, Stahl W, Sies H, Lirussi F, Donner A, Haussinger D. Plasma levels of vitamin E and carotenoids are decreased in patients with nonalcoholic steatohepatitis (NASH). Eur J Med Res 2011;16:76-8.
16. Astorg P, Gradelet S, Berges R, Suschetet M. Dietary lycopene decreases the initiation of liver preneoplastic foci by diethylnitrosamine in the rat. Nutr Cancer 1997;29:60-8.
17. Melendez-Martinez AJ, Nascimento AF, Wang Y, Liu C, Mao Y, Wang X-D. Effect of tomato extract supplementation against high-fat diet-induced hepatic lesions. Hepatobiliary Surg Nutr 2013;2:198.
18. Sahin K, Orhan C, Tuzcu M, Sahin N, Ali S, Bahcecioglu IH, et al. Orally administered lycopene attenuates diethylnitrosamine-induced hepatocarcinogenesis in rats by modulating Nrf-2/HO-1 and Akt/mTOR pathways. Nutr Cancer 2014;66:590-8.
19. Toledo LP, Ong TP, Pinho AL, Jordao A Jr, Vanucchi H, Moreno FS. Inhibitory effects of lutein and lycopene on placental glutathione S-transferase-positive preneoplastic lesions and DNA strand breakage induced in Wistar rats by the resistant hepatocyte model of hepato-carcinogenesis. Nutr Cancer 2003;47:62-9.
20. Wang Y, Ausman LM, Greenberg AS, Russell RM, Wang XD. Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats. Int J Cancer 2010;126:1788-96.
21. Ip BC, Wang X-D. Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention. Nutrients 2014;6: 124-62.
22. Kiefer C, Hessel S, Lampert JM, Vogt K, Lederer MO, Breithaupt DE, et al. Identification and characterization of a mammalian enzyme catalyzing the asymmetric oxidative cleavage of provitamin A. J Biol Chem 2001;276:14110-6.
23. Hu KQ, Liu C, Ernst H, Krinsky NI, Russell RM, Wang XD. The biochemical characterization of ferret carotene-9',10'-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. J Biol Chem 2006;281:19327-38.
24. Ip BC, Hu KQ, Liu C, Smith DE, Obin MS, Ausman LM, et al. Lycopene metabolite, apo-10'-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat diet-promoted hepatic inflammation and tumorigenesis in mice. Cancer Prev Res 2013;6:1304-16.
25. Lietz G, Oxley A, Boesch-Saadatmandi C, Kobayashi D. Importance of beta-carotene 15,15'-monooxygenase 1 (BCMO1) and beta-carotene 9',10'-dioxygenase 2 (BCDO2) in nutrition and health. Mol Nutr Food Res 2012;56:241-50.
26. Vesselinovitch SD, Mihailovich N, Rao KV. Morphology and metastatic nature of induced hepatic nodular lesions in C57BL × C3H F1 mice. Cancer Res 1978;38:2003-10.
27. Amengual J, Lobo GP, Golczak M, Li HNM, Klimova T, Hoppel CL, et al. A mitochondrial enzyme degrades carotenoids and protects against oxidative stress. FASEB J 2011;25:948-59.
28. Huang C-S, Chuang C-H, Hu M-L. Effects of lycopene supplementation on plasma and tissue lycopene levels in various rodent strains. Int J Vitam Nutr Res 2006;76:377-84.
29. Lian F, Smith DE, Ernst H, Russell RM, Wang XD. Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. Carcinogenesis 2007;28:1567-74.
30. Chung J, Koo K, Lian F, Hu KQ, Ernst H, Wang XD. Apo-10'-lycopenoic acid, a lycopene metabolite, increases sirtuin 1 mRNA and protein levels and decreases hepatic fat accumulation in ob/ob mice. J Nutr 2012;142:405-10.
31. Sharma V, McNeill JH. To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol 2009;157:907-21.
32. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008;22:659-61.
33. Riso P, Visioli F, Grande S, Guarnieri S, Gardana C, Simonetti P, et al. Effect of a tomato-based drink on markers of inflammation, immunomodulation, and oxidative stress. J Agric Food Chem 2006;54:2563-6.
34. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74.
35. Hill-Baskin AE, Markiewski MM, Buchner DA, Shao H, DeSantis D, Hsiao G, et al. Diet-induced hepatocellular carcinoma in genetically predisposed mice. Hum Mol Genet 2009;18:2975-88.
36. Menon S, Yecies JL, Zhang HH, Howell JJ, Nicholatos J, Harputlugil E, et al. Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Sci Signal 2012;5:ra24.
37. Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, et al. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 2010;70: 5184-93.
38. Wang X, Chen J, Li F, Lin Y, Zhang X, Lv Z, et al. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of beta-catenin. Biochem Biophys Res Commun 2012;428:525-31.
39. ∗ regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J Biol Chem 2008;283: 18158-66.
40. Xia H, Ooi LLPJ, Hui KM. MiR-214 Targets ß-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PLoS ONE 2012;7:e44206.
41. Duan Q, Wang X, Gong W, Ni L, Chen C, He X, et al. ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer. PLoS ONE 2012;7:e31518.
42. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011;19:232-43.
43. Schmitz HH, Poor CL, Wellman R, Erdman JW Jr. Concentrations of selected carotenoids and vitamin A in human liver, kidney and lung tissue. J Nutr 1991;121:1613.
44. Shuda M, Kondoh N, Imazeki N, Tanaka K, Okada T, Mori K, et al. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol 2003;38:605-14.
45. Lerner AG, Upton J-P, Praveen P, Ghosh R, Nakagawa Y, Igbaria A, et al. IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab 2012;16:250-64.
46. Maurel M, Chevet E. Endoplasmic reticulum stress signaling: the microRNA connection. Am J Physiol Cell Physiol 2013;304: C1117-C26.
47. Oikawa D, Tokuda M, Hosoda A, Iwawaki T. Identification of a consensus element recognized and cleaved by IRE1α. Nucleic Acids Res 2010;38:6265-73.
48. Kimball SR, Horetsky RL, Ron D, Jefferson LS, Harding HP. Mammalian stress granules represent sites of accumulation of stalled translation initiation complexes. Am J Physiol Cell Physiol 2003;284:C273-C84.
49. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012;149:274-93.
50. Tan H-L, Moran NE, Cichon MJ, Riedl KM, Schwartz SJ, Erdman JW, et al. β-carotene-9', 10'-oxygenase status modulates the impact of dietary tomato and lycopene on hepatic nuclear receptor-, stress-, and metabolism-related gene expression in mice. J Nutr 2014;144:431-9.
51. Takitani K, Zhu C-L, Inoue A, Tamai H. Molecular cloning of the rat β-carotene 15, 15'-monooxygenase gene and its regulation by retinoic acid. Eur J Nutr 2006;45:320-6.
52. von Lintig J, Vogt K. Filling the gap in vitamin A research. Molecular identification of an enzyme cleaving β-carotene to retinal. J Biol Chem 2000;275:11915-20.
53. Wyss A, Wirtz G, Woggon W-D, Brugger R, Wyss M, Friedlein A, et al. Cloning and expression of β, β-carotene 15, 15'-dioxygenase. Biochem Biophys Res Commun 2000;271:334-6.
54. Lindqvist A, Andersson S. Biochemical properties of purified recombinant human β-carotene 15, 15'-monooxygenase. J Biol Chem 2002;277:23942-8.
55. dela Sena C, Narayanasamy S, Riedl KM, Curley RW, Schwartz SJ, Harrison EH. Substrate specificity of purified recombinant human β-carotene 15, 15'-oxygenase (BCO1). J Biol Chem 2013;288: 37094-103.
56. Redmond TM, Gentleman S, Duncan T, Yu S, Wiggert B, Gantt E, et al. Identification, expression, and substrate specificity of a mammalian β-carotene 15, 15'-dioxygenase. J Biol Chem 2001;276:6560-5.
57. Takai K, Okuno M, Yasuda I, Matsushima-Nishiwaki R, Uematsu T, Tsurumi H, et al. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Intervirology 2005;48:39-45.
58. Kloer DP, Ruch S, Al-Babili S, Beyer P, Schulz GE. The structure of a retinal-forming carotenoid oxygenase. Science 2005;308:267-9.
59. Maeda T, Perusek L, Amengual J, Babino D, Palczewski K, von Lintig J. Dietary 9-cis-β, β-carotene fails to rescue vision in mouse models of leber congenital amaurosis. Mol Pharmacol 2011;80:943-52.
60. Sui X, Kiser PD, Lintig Jv, Palczewski K. Structural basis of carotenoid cleavage: from bacteria to mammals. Arch Biochem Biophys 2013; 539:203-13.